Zai Lab Shares Outstanding 2016-2022 | ZLAB
Zai Lab shares outstanding from 2016 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Zai Lab Annual Shares Outstanding
(Millions of Shares) |
| 2021 |
93 |
| 2020 |
78 |
| 2019 |
64 |
| 2018 |
53 |
| 2017 |
22 |
| 2016 |
9 |
| 2015 |
9 |
Zai Lab Quarterly Shares Outstanding
(Millions of Shares) |
| 2022-09-30 |
96 |
| 2022-06-30 |
96 |
| 2022-03-31 |
96 |
| 2021-12-31 |
93 |
| 2021-09-30 |
95 |
| 2021-06-30 |
93 |
| 2021-03-31 |
88 |
| 2020-12-31 |
78 |
| 2020-09-30 |
75 |
| 2020-06-30 |
|
| 2020-03-31 |
73 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$4.354B |
$0.144B |
|
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
|
